Company Ambalal Sarabhai Enterprises Limited

AMBALALSA6

INE432A01017

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 05:00:53 2025-12-09 am EST			5-day change	1st Jan Change
26.98 ^INR	+2.24%		-5.40%	-49.65%

Nov. 12	Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
Aug. 13	Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI

Business description: Ambalal Sarabhai Enterprises Limited

Ambalal Sarabhai Enterprises Limited is an India-based company that is engaged in the business of manufacturing pharmaceuticals and electronics. The Company's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparation (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in oncology, infertility and Uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Private Limited, is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited, is a manufacturer of analytical and test and measuring instruments distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.

Number of employees: 547

Sales by Activity: Ambalal Sarabhai Enterprises Limited

Fiscal Period: March	2021	2022	2023	2024	2025
Pharmaceuticals	1.08B	1.37B	1.01B	927M	1.08B
Electronics	561M	602M	689M	809M	878M

See all business segments

Geographical breakdown of sales: Ambalal Sarabhai Enterprises Limited

Fiscal Period: March	2021	2022	2023	2024	2025
India	1B	1.25B	1.01B	1.17B	1.27B
Rest of The World	636M	715M	689M	562M	695M

See all geographic segments

Executive Committee: Ambalal Sarabhai Enterprises Limited

Manager	Title	Age	Since
Jinal Jaykumar Shah DFI	Director of Finance/CFO	-	2024-07-25
Disha Mahesh Punjani CMP	Compliance Officer	32	2023-10-16

See AMBALAL SARABHAI ENTERPRISES LIMITED governance

Composition of the Board of Directors: Ambalal Sarabhai Enterprises Limited

Director	Title	Age	Since
Kartikeya Vikram Sarabhai CHM	Chairman	78	1994-12-31
Chaula M. Shastri BRD	Director/Board Member	66	2012-10-15
Mayur Kishorchandra Swadia BRD	Director/Board Member	64	2020-08-19
Brijesh Khandelwal BRD	Director/Board Member	72	2023-09-07
Govindprasad Namdeo BRD	Director/Board Member	73	2023-12-28
Ajay Mayor BRD	Director/Board Member	39	2023-12-28
Bharatendu P. Jani BRD	Director/Board Member	73	2023-12-28
Satyen R. Dave BRD	Director/Board Member	41	2024-03-31
Pushpa T. Robin BRD	Director/Board Member	41	2024-03-31

Composition of the Board of Directors

Shareholders: Ambalal Sarabhai Enterprises Limited

Name	Equities	%	Valuation
Sarabhai Holdings Ltd. 25.76 %	19,742,348	25.76 %	6 M ₹

List of AMBALAL SARABHAI ENTERPRISES LIMITED shareholders

Company details: Ambalal Sarabhai Enterprises Limited

Ambalal Sarabhai Enterprises Ltd.

Shanti Sadan

380001, Ahmedabad

http://www.ase.life

address Ambalal Sarabhai Enterprises Limited(AMBALALSA6)

Generic Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
AMBALAL SARABHAI ENTERPRISES LIMITED	+2.24%	-5.40%	-53.78%	-0.99%	22.43M
SUN PHARMACEUTICAL INDUSTRIES LTD.	-1.12%	-1.74%	-1.60%	+81.08%	47.8B
SANDOZ GROUP AG	+0.10%	+3.91%	+53.70%	-	31.39B
OTSUKA HOLDINGS CO., LTD.	+0.44%	+6.15%	+4.68%	+103.67%	31.09B
CIPLA LIMITED	-0.47%	-2.13%	+0.89%	+34.59%	13.42B
ZYDUS LIFESCIENCES LIMITED	-0.47%	-1.73%	-7.52%	+123.33%	10.32B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+0.74%	+0.13%	+83.48%	+87.77%	9.56B
KRKA, D. D.	-0.99%	-2.44%	+46.52%	+112.31%	7.15B
THE MEDICINES COMPANY	-.--%	+0.14%	-	-	6.79B
ONO PHARMACEUTICAL CO., LTD.	+2.07%	+1.67%	+24.65%	-36.71%	6.39B
Average	+0.25%	-0.15%	+16.78%	+63.13%	16.39B
Weighted average by Cap.	-0.22%	+1.44%	+18.94%	+81.45%